NNew Zealand Read More Eye Institute expands into HamiltonOctober 9, 2026 Dr Thompson, who also serves as RANZCO’s censor-in-chief, overseeing postgraduate ophthalmology education and training standards across New Zealand…
NNew Zealand Read More Optometrists empowering humans | NZ OpticsOctober 8, 2026 Skip to main contentOptometrists empowering humans | NZ Optics At Richmond OPSM, optometrist Shankari Ganeshan has welcomed dry…
TTechnology Read More New at-home electronic heating device for MGDSeptember 23, 2026 References 1. Stapleton F, Argueso P, Asbell P, Azar D, Bosworth C, Chen W, et al. TFOS DEWS…
MMedication Read More An Oral Ketamine Drug for Depression — Minus the Trip?July 17, 2026 A novel oral ketamine drug was well tolerated and associated with reduced depressive symptoms in treatment-resistant depression (TRD)…
HHealth Read More Blood Test Boosts Alzheimer’s Diagnosis Accuracy in Primary Care: AAIC 2026 StudyJuly 16, 2026 Blood test results allow primary care physicians to diagnose Alzheimer’s disease with nearly the same accuracy as specialists,…
NNew Zealand Read More Presbyopia-correcting ICL arrives in New ZealandJuly 15, 2026 Sonderegger said accurate sizing is critical because ICLs are positioned in the ciliary sulcus behind the iris, an…
HHealth Read More Keeping clinicians in the loop with IOL designsJuly 15, 2026 The company also showcased the Acunex VarioMax and VarioMax Toric lenses. The Vario Max is designed to deliver…
HHealth Read More Blood Test Predicts Chemotherapy Benefit in Colorectal Cancer, Study FindsJuly 6, 2026 A blood test may help identify which patients with colorectal cancer that has spread to the liver are…
HHealth Read More NIH Study: Blood Test Using Circular RNAs Predicts Alzheimer’s ProgressionJuly 6, 2026 Elevated levels of specific circular RNAs in the blood nearly tripled the risk of developing Alzheimer’s disease symptoms,…
MMedication Read More GLP-1s for Addiction: Are We There Yet?July 3, 2026 Substance use disorders (SUDs) may become the next therapeutic target for GLP-1 receptor agonists (GLP-1s). Although the evidence…
HHealth Read More Global push to recognise threat of toxoplasmosis – NZ OpticsJuly 2, 2026 Global push to recognise threat of toxoplasmosis NZ OpticsCat parasite infecting third of humans is ‘major cause of vision…
HHealth Read More A case of pigmented paravenous retinochoroidal atrophyJune 20, 2026 Fig 2a–d. Ultra-widefield imaging (top two images) showing perivascular pigmentary changes and fundus auto-fluorescence (bottom two images) of…